Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP673448.RAR4RMd_a21hRrwbiMPztKkANhDGVRGbYeTn2mSREPKQM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP673448.RAR4RMd_a21hRrwbiMPztKkANhDGVRGbYeTn2mSREPKQM130_assertion type Assertion NP673448.RAR4RMd_a21hRrwbiMPztKkANhDGVRGbYeTn2mSREPKQM130_head.
- NP673448.RAR4RMd_a21hRrwbiMPztKkANhDGVRGbYeTn2mSREPKQM130_assertion wasGeneratedBy ECO_0000203 NP673448.RAR4RMd_a21hRrwbiMPztKkANhDGVRGbYeTn2mSREPKQM130_provenance.
- NP673448.RAR4RMd_a21hRrwbiMPztKkANhDGVRGbYeTn2mSREPKQM130_assertion wasDerivedFrom befree-20150227 NP673448.RAR4RMd_a21hRrwbiMPztKkANhDGVRGbYeTn2mSREPKQM130_provenance.
- NP673448.RAR4RMd_a21hRrwbiMPztKkANhDGVRGbYeTn2mSREPKQM130_assertion SIO_000772 24335499 NP673448.RAR4RMd_a21hRrwbiMPztKkANhDGVRGbYeTn2mSREPKQM130_provenance.
- NP673448.RAR4RMd_a21hRrwbiMPztKkANhDGVRGbYeTn2mSREPKQM130_assertion evidence source_evidence_literature NP673448.RAR4RMd_a21hRrwbiMPztKkANhDGVRGbYeTn2mSREPKQM130_provenance.
- NP673448.RAR4RMd_a21hRrwbiMPztKkANhDGVRGbYeTn2mSREPKQM130_assertion description "[The bromodomain and extraterminal (BET) protein BRD2-4 inhibitors hold therapeutic promise in preclinical models of hematologic malignancies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP673448.RAR4RMd_a21hRrwbiMPztKkANhDGVRGbYeTn2mSREPKQM130_provenance.